0001144204-17-033908.txt : 20170623
0001144204-17-033908.hdr.sgml : 20170623
20170623202632
ACCESSION NUMBER: 0001144204-17-033908
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170621
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENDHEIM JACK
CENTRAL INDEX KEY: 0001241560
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 17928760
MAIL ADDRESS:
STREET 1: C/O EMPIRE RESOURCES, INC.
STREET 2: 1 PARKER PLAZA, SUIET 10
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
v469559_form4.xml
FORM 4
X0306
4
2017-06-21
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001241560
BENDHEIM JACK
300 FRANK W. BURR BLVD., STE 21
TEANECK
NJ
07666
1
1
1
0
President and CEO
Class A Common Stock
2017-06-21
4
C
0
48000
0
A
96000
I
See
Class A Common Stock
2017-06-21
4
S
0
16000
37.17
D
80000
I
See
Class A Common Stock
2017-06-22
4
S
0
16000
37.19
D
64000
I
See
Class A Common Stock
2017-06-23
4
S
0
16000
37.10
D
48000
I
See
Class B Common Stock
0
2017-06-21
4
C
0
48000
0
D
Class A Common Stock
48000
20670836
I
See
Class B Common Stock is convertible into Class A Common Stock at any time after issuance on a one-for-one basis, and has no expiration date.
The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.40, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $37.65, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.65, inclusive.
/s/ Thomas G. Dagger, as Attorney-in-Fact for BFI Co., LLC
2017-06-23